Phospholipid capture combined with non-linear chromatographic correction for improved serum metabolite profiling

被引:14
作者
Want, Elizabeth J.
Smith, Colin A.
Qin, Chuan
VanHorne, K. C.
Siuzdak, Gary
机构
[1] Scripps Res Inst, Ctr Mass Spect, La Jolla, CA 92037 USA
[2] Tandem Labs Slat Lake City, Salt Lake City, UT 84124 USA
基金
美国国家卫生研究院;
关键词
phospholipid; metabolite profiling; liquid chromatography; mass spectrometry; serum;
D O I
10.1007/s11306-006-0028-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum analysis with LC/MS can yield thousands of potential metabolites. However, in metabolomics, biomarkers of interest will often be of low abundance, and ionization suppression from high abundance endogenous metabolites such as phospholipids may prevent the detection of these metabolites. Here a cerium-modified column and methyl-tert-butyl-ether (MTBE) liquid-liquid extraction were employed to remove phospholipids from serum in order to obtain a more comprehensive metabolite profile. XCMS, an in-house developed data analysis software platform, showed that the intensity of existing endogenous metabolites increased, and that new metabolites were observed. This application of phospholipid capture in combination with XCMS non-linear data processing has enormous potential in metabolite profiling, for biomarker detection and quantitation.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 31 条
[1]  
Bennett P., 2004, 52 ASMS C MASS SPECT
[2]  
Bennett PK, 2003, AM ASS PHARM SCI C S
[3]  
Creighton T.E., 1983, PROTEINS STRUCTURES
[4]   The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by 1H nuclear magnetic resonance spectroscopy [J].
Daykin, CA ;
Foxall, PJD ;
Connor, SC ;
Lindon, JC ;
Nicholson, JK .
ANALYTICAL BIOCHEMISTRY, 2002, 304 (02) :220-230
[5]   Multidimensional separations in the pharmaceutical arena [J].
Guttman, A ;
Varoglu, M ;
Khandurina, J .
DRUG DISCOVERY TODAY, 2004, 9 (03) :136-144
[6]  
Janson J.-C., 1998, PROTEIN PURIFICATION
[7]  
KHAN K, 1991, CLIN CHEM, V37, P728
[8]  
Meng M, 2004, 52 ASMS C MASS SPECT
[9]   The emerging role of lysophosphatidic acid in cancer [J].
Mills, GB ;
Moolenaar, WH .
NATURE REVIEWS CANCER, 2003, 3 (08) :582-591
[10]   The ins and outs of lysophosphatidic acid signaling [J].
Moolenaar, WH ;
van Meeteren, LA ;
Giepmans, BNG .
BIOESSAYS, 2004, 26 (08) :870-881